13F Portfolios

a16z Capital Management, L.L.C. — BIOAGE LABS INC BIOA: Quarterly 13F Position History

a16z Capital Management, L.L.C. has reported BIOAGE LABS INC (BIOA) on 7 13F-HR filings in Pactolio's tracked window, first appearing in Q3 2024. As of Q1 2026, the position is sized at 3,233,170 shares ($56.5M market value, 4.38% of the equity book).

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 3,233,170 0 $56.5M 4.38% $17.49
Q4 2025 3,233,170 0 $44.1M 2.79% $13.63
Q3 2025 3,233,170 0 $19.0M 1.36% $5.88
Q2 2025 3,233,170 0 $13.4M 4.27% $4.13
Q1 2025 3,233,170 0 $12.2M 1.73% $3.76
Q4 2024 3,233,170 +219,195 +7.3% $18.7M 2.51% $5.79
Q3 2024 3,013,975 $62.7M 5.51% $20.80

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did a16z Capital Management, L.L.C. first disclose a BIOA position in 13F-HR filings?

a16z Capital Management, L.L.C. first reported BIOAGE LABS INC (BIOA) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.

What was a16z Capital Management, L.L.C.'s most recent quarter-over-quarter share-count change in BIOA?

a16z Capital Management, L.L.C. held the same 3,233,170 shares of BIOA between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent a16z Capital Management, L.L.C.'s cost basis in BIOA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.